Copper IUD for Emergency Contraception: Timing Window
A copper IUD can be inserted within 5 days (120 hours) of unprotected intercourse for emergency contraception, or up to 5 days after ovulation when the timing of ovulation can be estimated. 1
Standard Timing Window
The primary guideline is straightforward:
- Insert within 5 days of unprotected intercourse for standard emergency contraception use 1
- This 5-day window applies to the first act of unprotected intercourse if there were multiple episodes 2
Extended Window Based on Ovulation Timing
When you can estimate ovulation timing, you have more flexibility:
- The copper IUD can be inserted beyond 5 days after intercourse, as long as insertion occurs no more than 5 days after ovulation 1, 2
- This means if a woman had unprotected sex on day 10 of her cycle but ovulation occurred on day 14, you could insert the IUD up to day 19 (5 days post-ovulation), which would be 9 days after the intercourse 1
Evidence for Extended Timing
Recent research supports even broader windows:
- Studies have documented successful copper IUD placement up to 14 days after unprotected intercourse with a failure rate of only 0.12% 3
- One study specifically evaluated placement 6-14 days after unprotected intercourse and found zero pregnancies (0%, 97.5% CI 0-2.7%) 4
Effectiveness
The copper IUD is the most effective emergency contraceptive available:
- Failure rate of approximately 0.09-0.12% across multiple studies 3, 5
- Significantly more effective than oral emergency contraception methods 5
- Provides the added benefit of long-term contraception for up to 10+ years after insertion 6, 5
Important Caveats
Contraindications to immediate insertion:
- Pregnancy (Category 4 - unacceptable health risk) 1
- High risk for STI, particularly chlamydia or gonorrhea (Category 3 - risks usually outweigh benefits) 1
- Low STI risk is Category 1 (no restrictions) 1
Clinical pearl: The copper IUD is vastly underutilized for emergency contraception despite being the most effective option. Many providers and patients are unaware of this indication 3.